James Engelhart, Chief Financial Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 147,150 shares at $66.66 ($9.7M) on 2020-06-10, disclosed to the SEC on 2020-06-12.
Open-market sale of $9.7M BHVN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.66 | 28,821 | $1.9M | 19.8% |
| 2 | $66.66 | 28,821 | $1.9M | 19.8% |
| 3 | $67.53 | 24,832 | $1.7M | 17.2% |
| 4 | $67.53 | 24,832 | $1.7M | 17.2% |
| 5 | $68.07 | 300 | $20K | 0.2% |
| 6 | $62.07 | 5,972 |
| $371K |
| 3.8% |
| 7 | $62.07 | 5,972 | $371K | 3.8% |
| 8 | $63.19 | 4,847 | $306K | 3.1% |
| 9 | $63.19 | 4,847 | $306K | 3.1% |
| 10 | $64.31 | 6,501 | $418K | 4.3% |
| 11 | $64.31 | 6,501 | $418K | 4.3% |
| 12 | $64.85 | 2,452 | $159K | 1.6% |
| 13 | $64.85 | 2,452 | $159K | 1.6% |
| Total | $66.09 avg | 147,150 | $9.7M | 100% |
| Filing → |
| BHVN | SELL | 2018-05-30 | $175K | — | Filing → |
| BHVN | SELL | 2018-05-09 | $69K | — | Filing → |
| BHVN | SELL | 2018-02-23 | $16K | — | Filing → |